Support

Support Options

Submit a Support Ticket

 

Usage

Usage is calculated on the last day of every month. For more information on usage data, visit the Usage Overview page.

Table 1: Overview
Item Value
Contributions: 46
Total "and more" Users Served: 26,432
Rank by Contributions: 24 / 1452
First Contribution: 01 Sep 2005
Last Contribution: 11 Apr 2012
Citations on Contributions: 1
Table 2: Simulation Tool Usage
# Tool Name Users served in last 12 months Simulation Runs in last 12 months Total users served Total Simulation Runs Citations Published On
No data found.
Table 3: "and more" Usage
# Resource Title Users served in last 12 months Total users served Citations Published On
1 The Importance of Zeta Potential for Drug/Gene Delivery in Nanomedicine Online Presentations 1,602 2,481 - 11 Apr 2012
2 Malvern Instruments Workshop: Nano-particle Characterization Symposium Workshops 2,099 3,052 - 11 Apr 2012
3 BME 695L Lecture 16: FDA and EPA Regulatory Issues Online Presentations 200 379 - 02 Dec 2011
4 BME 695L Lecture 15: GMP and Issues of Quality Control Manufacture of Nanodelivery Systems Online Presentations 206 390 - 02 Dec 2011
5 BME 695L Lecture 12: Assessing Drug Efficacy and Nanotoxicity at the Single Cell Level Online Presentations 40 89 - 23 Nov 2011
6 BME 695L Lecture 13: Designing Nanomedical Systems (NMS) for In-vivo Use Online Presentations 58 148 - 23 Nov 2011
7 BME 695L Lecture 14: Designing and Testing Integrated Nanomedical Systems Online Presentations 41 103 - 23 Nov 2011
8 BME 695L Lecture 11: Assessing Nanotoxicity at the Single Cell Level Online Presentations 48 140 - 27 Oct 2011
9 BME 695L Lecture 10: Nanodelivery of Therapeutic Genes and Molecular Biosensor Feedback Control Systems Online Presentations 52 130 - 26 Oct 2011
10 BME 695L Lecture 9: Challenges of Proper Drug Dosing with Nanodelivery Systems Online Presentations 31 83 - 19 Oct 2011
11 BME 695L Lecture 8: Surface Chemistry: attaching nanomedical structures to the core Online Presentations 46 135 - 12 Oct 2011
12 BME 695L Lecture 6: Normal & Facilitated Cell Entry Mechanisms Online Presentations 36 102 - 04 Oct 2011
13 BME 695L Lecture 7: Assessing Zeta Potentials Online Presentations 79 208 - 03 Oct 2011
14 BME 695L Lecture 5: Nanomaterials for Core Design Online Presentations 64 191 - 03 Oct 2011
15 BME 695L Lecture 4: Cell Targeting and its Evaluation Online Presentations 52 130 - 03 Oct 2011
16 BME 695L Lecture 3: Theranostics and Molecular Imaging Online Presentations 76 198 - 07 Sep 2011
17 BME 695L Lecture 2: Designing Nanomedical Systems Online Presentations 176 348 - 31 Aug 2011
18 BME 695L: Engineering Nanomedical Systems Courses 1,395 3,297 - 31 Aug 2011
19 BME 695L Lecture 1: Need for New Perspectives on Medicine Online Presentations 541 1,485 - 31 Aug 2011
20 Nanomedicine – How Can Something so Small be so Huge for the Future of Healthcare? Online Presentations 24 167 - 17 Jun 2010
21 Optical BioMEMS Microfluidic Technologies for Hand-Held, Point-of-Care, Medical Devices Online Presentations 64 366 - 23 Nov 2009
22 Design of Multi-Component, Multi-Functional Nanomedical Systems for Drug/Gene Delivery and Theragnostics Online Presentations 3 102 - 02 Jul 2008
23 Ethics of Stem Cells and Therapeutic Cloning Online Presentations 8 675 - 27 Nov 2007
24 BME 695N Lecture 21: FDA and EPA Regulatory Issues Online Presentations 55 647 - 27 Nov 2007
25 Engineering Nanomedical Systems Online Presentations 40 951 - 16 Nov 2007
26 BME 695N Lecture 20: GMP and issues of quality control manufacture of nanodelivery systems Online Presentations 51 925 - 15 Nov 2007
27 BME 695N Lecture 18: Designing nanodelivery systems for in-vivo use Online Presentations 46 904 - 12 Nov 2007
28 BME 695N Lecture 17: Assessing nanotoxicity at the single cell level Online Presentations 62 1,202 - 06 Nov 2007
29 BME 695N Lecture 16: Assessing drug efficacy at the single cell level Online Presentations 74 910 - 02 Nov 2007
30 BME 695N Lecture 15: Nanodelivery of therapeutic genes & molecular biosensor feedback control systems Online Presentations 91 1,627 - 30 Oct 2007
31 BME 695N Lecture 14: Challenges of proper drug dosing with nanodelivery systems Online Presentations 47 776 - 29 Oct 2007
32 BME 695N Lecture 13: Assessing Zeta Potentials Online Presentations 145 1,600 - 29 Oct 2007
33 KIST/PU Multi-Component, Multi-Functional Nanomedical Systems for Drug/Gene Delivery Online Presentations 38 856 - 23 Oct 2007
34 BME 695N Lecture 6: Rare-event targeting of cells in-vitro and in-vivo Online Presentations 37 718 - 26 Sep 2007
35 BME 695N Lecture 10: Nanomaterials for core design Online Presentations 66 1,607 - 26 Sep 2007
36 BME 695N Lecture 8: Technologies for measuring nanomedical systems on/within cells Online Presentations 39 910 - 24 Sep 2007
37 BME 695N Lecture 7: Normal & facilitated cell entry mechanisms Online Presentations 33 621 - 16 Sep 2007
38 BME 695N Lecture 5: Cell Targeting Online Presentations 61 1,115 - 12 Sep 2007
39 BME 695N Lecture 4: Designing "Theragnostic" Systems Online Presentations 67 1,473 - 04 Sep 2007
40 BME 695N Lecture 3: Overview of Basic Nanomedical Systems Design Online Presentations 46 755 - 29 Aug 2007
41 BME 695N: Engineering Nanomedical Systems (Fall 2007) Courses 778 16,427 1 28 Aug 2007
42 BME 695N Lecture 2: Basic Concepts of Nanomedical Systems Online Presentations 73 1,189 - 28 Aug 2007
43 BME 695N Lecture 1: Need for New Perspectives on Medicine Online Presentations 87 1,419 - 03 Aug 2007
44 Nanotechnologies, Science and Society: Promises and Challenges Online Presentations 29 885 - 10 May 2007
45 Engineering Nanomedical Systems Online Presentations 34 2,116 - 14 Mar 2006
46 Nanofactories - In - Situ Production of Therapeutic Genes... Online Presentations 17 596 - 01 Sep 2005
TOTAL 4,187 26,432
* Total only includes versions of the tools this author contributed to.

nanoHUB.org, a resource for nanoscience and nanotechnology, is supported by the National Science Foundation and other funding agencies. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.